Medication info
Ciprofloxacin 250 mg Tablets (Ciprofloxacin Hydrochloride Monohydrate)

Ciprofloxacin 250 mg Tablets (Ciprofloxacin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Jeongwoo Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903428 · Approved 2019.05.27 · Insurance code 694205700

Summary

Main use
Treatment of genitourinary, respiratory, ENT and ocular, abdominal, skin, and osteoarticular infections
Who takes it
Adults
Adult dose
○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg per dose, twice daily between meals. For severe complicated infections, the dose of this medication may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only the serum creatinine level is known, creatinine clearance can be calculated using the following formula: Men: {weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Jeongwoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of genitourinary, respiratory, ENT and ocular, abdominal, skin, and osteoarticular infections

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
  • complicated urinary tract infections
View approved original text

This drug is used to treat infections caused by various bacteria. It is effective against several types of respiratory infections, excluding acute bronchitis, and community-acquired pneumonia, and can also be used for infections of the ear, nose, and throat. Furthermore, it is widely used for urinary tract infections, gonococcal cervicitis and urethritis, gastrointestinal and biliary tract infections, skin and soft tissue infections, bone and joint infections, etc. It is also applicable to gynecological infections, peritonitis, dacryocystitis, and lesions around the eyes such as chalazion. However, as a fluoroquinolone drug, there may be some serious adverse reactions, so it should be used only when there are no other treatment options for certain mild infections (acute bacterial rhinosinusitis, exacerbations of chronic bronchitis or lung disease, uncomplicated urinary tract infection, acute otitis media). Overall, this medication is used effectively to improve various bacterial infections.

How to take

Adult dose

○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg per dose, twice daily between meals. For severe complicated infections, the dose of this medication may be increased to 750 mg per dose, twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose, twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only the serum creatinine level is known, creatinine clearance can be calculated using the following formula: Men: {weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose appropriately according to symptoms.

Precautions

This medication may cause serious side effects such as tendinitis or tendon rupture, peripheral neuropathy, and central nervous system anomalies, so caution is required. In particular, patients with myasthenia gravis may experience worsening symptoms from taking this medication and should avoid it. Additionally, this drug should be used only for limited infections such as acute bacterial rhinosinusitis, acute exacerbations of chronic bronchitis, uncomplicated urinary tract infections, and acute otitis media, and only when no other treatment is available. It is not safe for elderly patients or those with impaired renal function, patients with epilepsy, pregnant or nursing women, and adolescents under 18 years of age. The risk of side effects may increase when used with certain medications, so any concurrent medications should be discussed with a doctor or pharmacist. If pain or inflammation in the tendon occurs during treatment, the medication should be discontinued immediately and rest should be taken, and it is advisable to avoid strong sunlight or ultraviolet exposure. This medication can cause various side effects including fluctuations in blood sugar, neurological abnormalities, liver function anomalies, gastrointestinal issues; therefore, if any unusual symptoms appear, medical personnel should be notified immediately. It is preferable not to use this medication during pregnancy or breastfeeding, and it should not be administered to children or adolescents in their growth phase. Overdose may result in kidney damage, so it is essential to stick to the prescribed dosage and store it out of reach of children and away from direct sunlight.

Side effects

tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, decrease in hemoglobin, decrease in hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increase in INR, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactoid reaction shock, serum sickness-like reaction, loss of appetite, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, paresthesia, sensory loss, taste loss, tremors, spasms, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal bloating, dyspepsia, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, hepatic impairment, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized erythematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, acute kidney failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undetermined pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, petechial rash, aneurysm, aortic dissection, cardiac valvular reflux, valvular insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is well-ventilated, and it is recommended to keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.